Can low cortisol signaling cause lower measured neutrophil counts?

Cortisol is a primary regulator of white blood cell distribution, and its presence is essential for maintaining standard circulating neutrophil levels. The relationship between cortisol and neutrophil counts is driven by specific physiological processes that shift these cells from tissue-adjacent pools into the active bloodstream.

Mechanistic basis of neutrophil demargination

The influence of cortisol on neutrophil counts is primarily mediated through "demargination." Under normal physiological conditions, a significant portion of the body's mature neutrophils are part of the "marginal pool," meaning they are adhered to the vascular endothelium (vessel walls) rather than circulating freely.

• Adhesion Molecule Modulation: Cortisol acts via glucocorticoid receptors (GR) to rapidly down-regulate the expression of L-selectin (CD62L) on the neutrophil surface. L-selectin is critical for the initial "tethering and rolling" that allows neutrophils to stick to vessel walls.
• Integrin Regulation: Cortisol also modulates beta-2 integrins (CD11/CD18). By reducing the expression or affinity of these molecules, cortisol decreases the physical adherence of neutrophils to the endothelium, effectively releasing them into the circulating pool.
• Chemokine Signaling: Beyond demargination, cortisol influences trafficking by upregulating the CXCR1/2 receptors (promoting mobilization) and downregulating the CXCR4 pathway, which normally retains neutrophils within the bone marrow.

Clinical evidence for low cortisol signaling

When cortisol signaling is insufficient, the absence of these demargination triggers results in lower measured circulating neutrophil counts.

• Adrenal Insufficiency: In conditions like Addison’s disease or secondary adrenal insufficiency, neutropenia (low neutrophil count) is a documented hematological manifestation. This occurs because the neutrophils remain "sequestered" in the marginal pool or the bone marrow due to the lack of cortisol-driven release signals.
• Reversibility with Treatment: Clinical data from case studies and endocrine research show that these low neutrophil counts are typically reversible. Upon administration of glucocorticoid replacement therapy (such as hydrocortisone), patients often experience a rapid normalization or elevation of circulating neutrophils as the demargination process is restored.

Bottom line

Cortisol signaling is a critical driver of neutrophil demargination; therefore, low cortisol states can lead to lower measured neutrophil counts. This occurs because the lack of cortisol prevents the down-regulation of adhesion molecules like L-selectin, causing neutrophils to remain adhered to vessel walls rather than entering the circulation.